Edition:
United States

Zafgen Inc (ZFGN.OQ)

ZFGN.OQ on NASDAQ Stock Exchange Global Select Market

11.10USD
3:27pm EDT
Change (% chg)

$0.72 (+6.94%)
Prev Close
$10.38
Open
$10.37
Day's High
$11.20
Day's Low
$10.37
Volume
73,960
Avg. Vol
107,731
52-wk High
$11.35
52-wk Low
$3.25

Chart for

About

Zafgen, Inc., is a clinical-stage biopharmaceutical company. The Company uses its proprietary methionine aminopeptidase 2 (MetAP2) biology platform to develop novel therapies for patients affected by complex metabolic diseases. Its product candidate is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor that is used to... (more)

Overall

Beta: -0.64
Market Cap(Mil.): $382.04
Shares Outstanding(Mil.): 36.81
Dividend: --
Yield (%): --

Financials

  ZFGN.OQ Industry Sector
P/E (TTM): -- 108.51 32.45
EPS (TTM): -2.09 -- --
ROI: -67.47 1.61 12.63
ROE: -75.70 0.35 14.80

BRIEF-Zafgen Reports Q1 Loss Per Share $0.58

* ZAFGEN REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

May 08 2018

Earnings vs. Estimates